Related Experiment Video For Cancer Research

Updated: Feb 18, 2026

Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
04:49

Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research

Published on: May 5, 2021

7.1K

Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs

Chengli Jian1, Hao Fu1, Wantao Wu2

  • 1Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.

Molecular Cancer
|February 17, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Cancer ResearchNAMsPDXPDX 2.0Precision Medicine

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

1.3K

Related Experiment Videos

Last Updated: Feb 18, 2026

Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
04:49

Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research

Published on: May 5, 2021

7.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

1.3K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Keywords:
Cancer ResearchNAMsPDXPDX 2.0Precision Medicine

Articles linked to this work by shared authors, journal, and citation graph.

Energy Conservation and Production Efficiency Enhancement in Herbal Medicine Extraction: Self-Adaptive Decision-Making Boiling Judgment via Acoustic Emission Technology.

Pharmaceuticals (Basel, Switzerland)·2025

High-entropy Mn-Prussian blue analogues enable long-term cycling in aqueous sodium-ion batteries through synergistic redox and ion diffusion enhancements.

Journal of colloid and interface science·2025

Association between long-term exposure to air pollutant mixture and the risk of Alzheimer's disease among older people: a prospective cohort study in China.

BMC public health·2025

[Influence of Exercise Prescription on the Recovery of Cognitive Function In College Students With Mild-to-Moderate Depression].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2025

A smart gene circuit for precise regulation of tumor cell behavior.

Synthetic and systems biotechnology·2025

Overexpression of RUNX2 promotes breast cancer multi-organ metastasis through stabilizing c-Myc.

Cell death & disease·2025

Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy.

Molecular cancer·2026

Ecosystem-matched reprogramming of the tumor-immune microenvironment to overcome cancer immunotherapy resistance.

Molecular cancer·2026

A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer.

Molecular cancer·2026

Programmable ZBTB7A RNA N6-methyladenosine site-specific demethylation suppresses colorectal cancer liver metastasis.

Molecular cancer·2026

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Molecular cancer·2026

Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies.

Molecular cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us